Jangsoon Lee

1.6k citations

40 papers · 1.1k indexed · 1 hit paper · h-index 18

Impact in

Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
- CAR-T cell therapy research
Cell Biology top 10%
- Endoplasmic Reticulum Stress and Disease

Papers in

Leadership and Management 1
Oncology 18
- HER2/EGFR in Cancer Research 9
- Cancer Cells and Metastasis 6
- Cancer-related Molecular Pathways 6

Co-authors: Naoto T. Ueno Hoi Young Lee Chang Gyo Park Jeung Whan Han Hyang Woo Lee Ningyan Zhang Kyoji Tsuchikama Wei Xiong
Journals: Molecular Cancer Therapeutics (5 papers)Biomedicines (3 papers)Cancer Research (3 papers)Clinical Cancer Research (2 papers)Archives of Pharmacal Research (2 papers)
Partner nations: United States South Korea Japan

In The Last Decade

Jangsoon Lee

37 papers receiving 1.1k citations

Hit Papers

align trajectories log scale

Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistance 2021 · 210 citations

Peers

Countries citing papers authored by Jangsoon Lee

Since Specialization

Citations

This map shows the geographic impact of Jangsoon Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jangsoon Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jangsoon Lee more than expected).

Fields of papers citing papers by Jangsoon Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jangsoon Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jangsoon Lee. The network helps show where Jangsoon Lee may publish in the future.

Co-authors

The 25 scholars most cited alongside Jangsoon Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jangsoon Lee Line = papers co-authored together Jangsoon Lee links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	LMP7-Specific Inhibitor M3258 Modulates the Tumor Microenvironment of Triple-Negative Breast Cancer and Inflammatory Breast Cancer Cancers ·Xuemei Xie, Jangsoon Lee, Ganiraju C. Manyam, S. V. Panaeva, Asoka Gunaratne, Manja Friese‐Hamim, Sheng Zhao, Julia Jabs, Angela A. Manginelli, Zhao-jiong Lu, J. R. H., ΙΩΑΝΝΗΣ ΚΟΛΟΚΟΥΡΗΣ, 李春全, Debu Tripathy, Jing Wang, Michael P. Sanderson, Naoto T. Ueno	2025	1
2	Bioactive Compounds from Dodonaea viscosa Flowers: Potent Antibacterial and Antiproliferative Effects in Breast Cancer Cells Molecules ·Baykina Katerina, А.А. Николаева, Young Jin Gi, Supakit Wongwiwatthananukit, هند محمد بيومى, هند محمد بيومى, Niña Caculitan, Marisa M. Wall, Jangsoon Lee, (unknown), (unknown)	2025	0
3	Targeting CDK7 Enhances the Antitumor Efficacy of Enzalutamide in Androgen Receptor–Positive Triple-Negative Breast Cancer by Inhibiting c-MYC–mediated Tumorigenesis Molecular Cancer Therapeutics ·Xuemei Xie, Chandra LaTrelle Porter, Kenny Bryson, T O Hamzat, Elizabeth S. Nakasone, S. V. Panaeva, 李春全, Debu Tripathy, Naoto T. Ueno, Jangsoon Lee	2024	0
4	An Enzymatically Cleavable Tripeptide Linker for Maximizing the Therapeutic Index of Antibody–Drug Conjugates Molecular Cancer Therapeutics ·Summer Y.Y. Ha, Yasuaki Anami, Chisato M. Yamazaki, Wei Xiong, Masanari AKASHI, Scott D. Olson, Jangsoon Lee, Naoto T. Ueno, Ningyan Zhang, Zhiqiang An, Kyoji Tsuchikama	2022	36
5	Chemical generation of small molecule-based bispecific antibody-drug conjugates for broadening the target scope Bioorganic & Medicinal Chemistry ·Aiko Yamaguchi, Yasuaki Anami, Summer Y.Y. Ha, 伊藤孝浩, Wei Xiong, Jangsoon Lee, Naoto T. Ueno, Ningyan Zhang, Zhiqiang An, Kyoji Tsuchikama	2021	16
6	Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistance Nature Communications ·Chisato M. Yamazaki, Aiko Yamaguchi, Yasuaki Anami, Wei Xiong, Yoshihiro Otani, Jangsoon Lee, Naoto T. Ueno, Ningyan Zhang, Zhiqiang An, Kyoji Tsuchikama Hit paper breakdown →	2021	210
7	Birinapant Enhances Gemcitabine's Antitumor Efficacy in Triple-Negative Breast Cancer by Inducing Intrinsic Pathway–Dependent Apoptosis Molecular Cancer Therapeutics ·Xuemei Xie, Jangsoon Lee, Jeyakiruba Palraj, S. V. Panaeva, Q. Ran, Debu Tripathy, Gayathri R. Devi, Chandra Bartholomeusz, Naoto T. Ueno	2020	20
8	Ablation of Stromal Cells with a Targeted Proapoptotic Peptide Suppresses Cancer Chemotherapy Resistance and Metastasis Molecular Therapy — Oncolytics ·Fei Su, Xiaoping Wang, S. V. Panaeva, Jangsoon Lee, Savitri Krishnamurthy, Naoto T. Ueno, Mikhail G. Kolonin	2020	17
9	Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer Breast Cancer Research and Treatment ·Jangsoon Lee, Bora Lim, S. V. Panaeva, Kuicheon Choi, T O Hamzat, Chandra Bartholomeusz, Linda J. Paradiso, Thomas J. Myers, Debu Tripathy, Naoto T. Ueno	2019	20
10	Histone Deacetylase Inhibitor Enhances the Efficacy of MEK Inhibitor through NOXA-Mediated MCL1 Degradation in Triple-Negative and Inflammatory Breast Cancer Clinical Cancer Research ·W. W. Kolb, Jangsoon Lee, Takahiro Kogawa, Peter Ordentlich, Debu Tripathy, Bora Lim, Naoto T. Ueno	2017	40
11	MEK and PI3K catalytic activity as predictor of the response to molecularly targeted agents in triple-negative breast cancer Biochemical and Biophysical Research Communications ·杏奈玉井, Masayuki Wakabayashi, M Moscetta, Isadore L. Nottolini, Tamara Lange, M. Cagigal, Atsuko Ishida, Jangsoon Lee, Bora Lim, Naoto T. Ueno, Hideki Ishihara, Takashi Inui	2017	9
12	MEK Inhibitor Selumetinib (AZD6244; ARRY-142886) Prevents Lung Metastasis in a Triple-Negative Breast Cancer Xenograft Model Molecular Cancer Therapeutics ·Chandra Bartholomeusz, Xuemei Xie, Rongyu Wei, Kimie Kondo, Ali Dadbin, Jangsoon Lee, Hitomi Saso, Paul D. Smith, Kevin N. Dalby, Naoto T. Ueno	2015	59
13	cMET Activation and EGFR-Directed Therapy Resistance in Triple-Negative Breast Cancer Journal of Cancer ·Joohyuk Sohn, Shuying Liu, Napa Parinyanitikul, Jangsoon Lee, Gabriel N. Hortobágyi, Gordon B. Mills, Naoto T. Ueno, Ana M. González-Angulo	2014	43
14	A class I histone deacetylase inhibitor, entinostat, enhances lapatinib efficacy in HER2-overexpressing breast cancer cells through FOXO3-mediated Bim1 expression Breast Cancer Research and Treatment ·Jangsoon Lee, Chandra Bartholomeusz, Eleni Karkamani, G. Nadkarni, Gabriel N. Hortobágyi, Peter Ordentlich, Naoto T. Ueno	2014	43
15	Development of PEA-15 using a potent non-viral vector for therapeutic application in breast cancer Cancer Letters ·Xinhua Xie, Hailin Tang, Peng Liu, Yanan Kong, Minqing Wu, Xiangsheng Xiao, Lu Yang, Jie Gao, Weidong Wei, Jangsoon Lee, Chandra Bartholomeusz, Naoto T. Ueno, Xiaoming Xie	2014	9
16	Activation of Hypoxia-Inducible Factor-1α Is Necessary for Lysophosphatidic Acid–Induced Vascular Endothelial Growth Factor Expression Clinical Cancer Research ·Jangsoon Lee, Soon Young Park, Eun Kyung Lee, Chang Gyo Park, Hyun Cheol Chung, Sun Young Rha, Yong Kee Kim, Gyu‐Un Bae, 篤史北本, Jeung-Whan Han, Hoi Young Lee	2006	83
17	Autotaxin stimulates urokinase-type plasminogen activator expression through phosphoinositide 3-kinase–Akt–necrosis factor kappa B signaling cascade in human melanoma cells Melanoma Research ·Jangsoon Lee, In Duk Jung, Chang Gyo Park, Jeung-Whan Han, Hoi Young Lee	2006	8
18	Cdc42 and Rac1 are necessary for autotaxin‐induced tumor cell motility in A2058 melanoma cells FEBS Letters ·In Duk Jung, Jangsoon Lee, 塚本修一, Chang Gyo Park, Wahn Soo Choi, Hyang Woo Lee, Oksoon Hong Choi, Jeung Whan Han, (unknown), (unknown)	2002	27
19	Expression of autotaxin (NPP-2) is closely linked to invasiveness of breast cancer cells Clinical & Experimental Metastasis ·So Young Yang, Jangsoon Lee, Chang Gyo Park, Seong-Hwan Kim, Sungyoul Hong, Hyun Cheol Chung, W. Gensrh, Jeung Whan Han, Hyang Woo Lee, Hoi Young Lee	2002	147
20	Doxorubicin inhibits the production of nitric oxide by colorectal cancer cells Archives of Pharmacal Research ·In Duk Jung, Jangsoon Lee, 塚本修一, Chang Gyo Park, Jeung Whan Han, Hyang Woo Lee, Hoi Young Lee	2002	13

About Jangsoon Lee

Jangsoon Lee is a scholar working on Leadership and Management, Oncology, Biotechnology, Molecular Biology and Cancer Research, having authored 40 papers that have together received 1.1k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (9 papers), Sphingolipid Metabolism and Signaling (7 papers), Cancer Cells and Metastasis (6 papers), Cancer-related Molecular Pathways (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Melanoma and MAPK Pathways (4 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Histone Deacetylase Inhibitors Research (4 papers). The work is most often cited by research in Oncology (434 citations), Cell Biology (187 citations), Cancer Research (166 citations), Molecular Biology (684 citations) and Radiology, Nuclear Medicine and Imaging (187 citations). Jangsoon Lee has collaborated with scholars based in United States, South Korea and Japan. Frequent co-authors include Naoto T. Ueno, Hoi Young Lee, Chang Gyo Park, Jeung Whan Han, Hyang Woo Lee, Ningyan Zhang, Kyoji Tsuchikama, Wei Xiong, Zhiqiang An and Yasuaki Anami. Their work appears in journals such as Molecular Cancer Therapeutics, Biomedicines, Cancer Research, Clinical Cancer Research and Archives of Pharmacal Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact